Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation

被引：20

作者：

Delabaudiere, Cyrielle ^{[1
]}

Lavayssiere, Laurence ^{[1
]}

Doerr, Gaelle ^{[1
]}

Muscari, Fabrice ^{[2
,3
]}

Danjoux, Marie ^{[4
]}

Sallusto, Federico ^{[5
]}

Peron, Jean Marie ^{[3
,6
]}

Bureau, Christophe ^{[3
,6
]}

Rostaing, Lionel ^{[1
,3
,7
]}

Izopet, Jacques ^{[3
,7
,8
]}

Kamar, Nassim ^{[1
,3
,7
]}

机构：

[1] CHU Rangueil, Dept Nephrol & Organ Transplantat, F-31059 Toulouse 9, France

[2] Univ Hosp Rangueil, Dept Surg & Liver Transplantat, Toulouse, France

[3] Univ Toulouse 3, F-31062 Toulouse, France

[4] CHU Purpan, Dept Pathol, Toulouse, France

[5] CHU Rangueil, Dept Urol & Kidney Transplantat, F-31059 Toulouse 9, France

[6] CHU Purpan, Dept Hepatol, Federat Digest, Toulouse, France

[7] CHU Purpan, IFR BMT, INSERM, U1043, Toulouse, France

[8] CHU Purpan, Virol Lab, Toulouse, France

来源：

TRANSPLANT INTERNATIONAL | 2015年 / 28卷 / 02期

关键词：

fibrosing cholestatic hepatitis; hepatitis C virus; kidney transplantation; liver transplantation; sofosbuvir; RECIPIENTS; THERAPY; PEGINTERFERON; INFECTION; ALPHA;

D O I：

10.1111/tri.12428

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Fibrosing cholestatic hepatitis (FCH) is a classical but rare and severe form of recurrent hepatitis C virus (HCV) after liver transplantation. Classical anti-HCV therapy, that is pegylated-interferon (peg-interferon) and ribavirin, has been shown to have limited efficacy in treating FCH. Herein, we report on the first case of successful use of peg-interferon, ribavirin, plus sofosbuvir to treat HCV-induced FCH in a combined liver-kidney transplant patient. Antiviral therapy was given for 24 weeks. HCV clearance occurred within 4 weeks after starting therapy and was maintained until 4 weeks after the end of therapy. Antiviral tolerance was good. We conclude that the use of sofosbuvir-based anti-HCV therapy can be successfully used to treat FCH after a liver or combined kidney-liver transplantation.

引用

页码：255 / 258

页数：4

共 50 条

[41] Successful Treatment of Fibrosing Cholestatic Hepatitis Following Kidney Transplantation With Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
Li, Dong Liang
Fang, Jian
Zheng, Zhiyong
Wu, Weizhen
Wu, Zhixian
MEDICINE, 2015, 94 (05) : e480
[42] Pegylated interferon plus ribavirin for the treatment of recurrent HCV infection after liver transplantation
Lorenzini, S
Biselli, M
Gramenzi, A
Bollino, F
Cursaro, C
Bernardi, M
Andreone, P
JOURNAL OF HEPATOLOGY, 2004, 40 : 144 - 144
[43] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
Seo, Kayo
Kim, Soo Ki
Kim, Soo Ryang
Ohtani, Aya
Kobayashi, Mana
Kato, Airi
Morimoto, Eri
Saijo, Yuka
Kim, Ke Ih
Imoto, Susumu
Kim, Chi Wan
Yano, Yoshihiko
Kudo, Masatoshi
Hayashi, Yoshitake
DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
[44] Single Center Experience with an Extended Treatment Protocol with Pegylated Interferon and Ribavirin for Hepatitis C Recurrence after Liver Transplantation
Thummalakunta, Laxmi
Araya, Victor
Tufail, Kashif
Hashemi, Nikroo
Feyssa, Eyob
Azhar, Ashaur
Niazi, Mumtaz A.
Ortiz, Jorge
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 82 - 82
[45] Successful treatment of hepatitis C reinfection with interferon-α2b and ribavirin after liver transplantation
Yedibela, S
Schuppan, D
Müller, V
Schellerer, V
Tannapfel, A
Hohenberger, W
Meyer, T
LIVER INTERNATIONAL, 2005, 25 (04) : 717 - 722
[46] Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure
Krawczyk, Marcin
Gaweda, Bartlomiej
Kosnik, Artur
Rejowski, Slawomir
Remiszewski, Piotr
Krawczyk, Marek
Milkiewicz, Piotr
Raszeja-Wyszomirska, Joanna
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (07): : 1062 - 1063
[47] Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir
Liu, Chen-Hua
Chen, Yih-Sharng
Wang, Sheoi-Shen
Kao, Jia-Horng
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (05) : 407 - 409
[48] Interferon-α and ribavirin for the treatment of recurrent hepatitis C after liver transplantation
de Vera, ME
Smallwood, GA
Rosado, K
Davis, L
Martinez, E
Sharma, S
Stieber, AC
Heffron, TG
TRANSPLANTATION, 2001, 71 (05) : 678 - 686
[49] Pegylated-interferon and ribavirin for recurrent hepatitis C after liver transplantation - A preliminary analysis.
Mukherjee, S
Gilroy, RK
McCashland, TM
Schafer, DF
Zetterman, RK
Sorrell, MF
HEPATOLOGY, 2002, 36 (04) : 184A - 184A
[50] Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
Fernandez, Inmaculada
Meneu, Juan Carlos
Colina, Francisco
Garcia, Ignacio
Munoz, Raquel
Castellano, Gregorio
Fuertes, Antonio
Abradelo, Manuel
Lumbreras, Carlos
Moreno, Enrique
Antonio Solis-Herruzo, Jose
LIVER TRANSPLANTATION, 2006, 12 (12) : 1805 - 1812

← 1 2 3 4 5 →